Xuedong Li

1.2k total citations
45 papers, 736 citations indexed

About

Xuedong Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xuedong Li has authored 45 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Xuedong Li's work include Ferroptosis and cancer prognosis (8 papers), Renal cell carcinoma treatment (5 papers) and Kidney Stones and Urolithiasis Treatments (4 papers). Xuedong Li is often cited by papers focused on Ferroptosis and cancer prognosis (8 papers), Renal cell carcinoma treatment (5 papers) and Kidney Stones and Urolithiasis Treatments (4 papers). Xuedong Li collaborates with scholars based in China, United States and India. Xuedong Li's co-authors include Hongyan Zhang, Zhengxiang Zhang, Xiaoyi Guo, Chun Chen, Jianjun Zhao, Bosen You, Wenfu Zhang, Guangmin Cong, Mingcai Chen and Yuhui Huang and has published in prestigious journals such as PLoS ONE, Oncogene and The Journal of Urology.

In The Last Decade

Xuedong Li

42 papers receiving 728 citations

Peers

Countries citing papers authored by Xuedong Li

Since Specialization

Citations

This map shows the geographic impact of Xuedong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuedong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuedong Li more than expected).

Fields of papers citing papers by Xuedong Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuedong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuedong Li. The network helps show where Xuedong Li may publish in the future.

Co-authorship network of co-authors of Xuedong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xuedong Li. A scholar is included among the top collaborators of Xuedong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuedong Li. Xuedong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CUL1-neddylation contributes to K29-linked ubiquitination on p27 for autophagic degradation in sorafenib-resistant liver cancer 2025 ·Cell Biology and Toxicology ·Haitao Xu, (unknown), Qiuqi Zhang, Ying Xu, Han‐Bo Zhang, (unknown), (unknown), (unknown), Xuedong Li, Ruitao Wang, Hongyan Liu, (unknown)	1
2	CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis 2025 ·Frontiers in Immunology ·Bo Han, Weiyang Liu, Wan‐Hui Wang, Zhuolun Li, Bosen You, Dongze Liu, Ying Nan, Tao Ding, Dai Zhou, (unknown), (unknown), Qing Liu, Xuedong Li	0
3	FTO downregulation-mediated m6A modification resulting in enhanced hepatocellular carcinoma invasion 2025 ·Cell & Bioscience ·Cheng Zhou, Yong Zhang, (unknown), Dan Yin, Xuedong Li, Ying‐Hong Shi, Jian Zhou, Zheng Wang, Qing Chen	3
4	Flexible Ureteroscopy with a Tip-bendable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy for Treatment of 2–3-cm Renal Stones: Study Protocol for an International, Multicenter, Randomized, Parallel-group, Noninferiority Trial 2024 ·European Urology Open Science ·Wei Zhu, Chu Ann Chai, Jinxiang Ma, Mehmet İlker Gökçe, Nariman Gadzhiev, (unknown), Kehua Jiang, Xianzhong Duan, Jianwei Cao, Rongpei Wu, Rijin Song, (unknown), Xuedong Li, (unknown), Guohua Zeng	4
5	DifFilter: Defending Against Adversarial Perturbations With Diffusion Filter 2024 ·IEEE Transactions on Information Forensics and Security ·(unknown), Xuedong Li, Peng Hu, Dezhong Peng, Xu Wang	4
6	Hexokinase HK3-mediated O-GlcNAcylation of EP300: a key regulator of PD-L1 expression and immune evasion in ccRCC 2024 ·Cell Death and Disease ·(unknown), (unknown), (unknown), Weiyang Liu, (unknown), Wenbin Hou, Nan Zhang, Yu Yang, Xuedong Li, (unknown)	3
7	The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features 2023 ·Frontiers in Pharmacology ·(unknown), Weiyang Liu, (unknown), Wei Zhang, Zhuolun Li, Nan Zhang, Wenbin Hou, (unknown), Xuedong Li, Bosen You	2
8	Tumor-associated macrophage-derived exosomes transmitting miR-193a-5p promote the progression of renal cell carcinoma via TIMP2-dependent vasculogenic mimicry 2022 ·Cell Death and Disease ·Qing Liu, (unknown), (unknown), (unknown), Hongyang Yu, Xinyang He, Xuedong Li, Guanglu Dong, Bosen You	52
9	Identification of a Five-miRNA Signature for Diagnosis of Kidney Renal Clear Cell Carcinoma 2022 ·Frontiers in Genetics ·(unknown), Xuedong Li, Bosen You, (unknown), Wenbin Hou, Qiong Wu	4
10	Tumor Cell–Derived TGFβ1 Attenuates Antitumor Immune Activity of T Cells via Regulation of PD-1 mRNA 2020 ·Cancer Immunology Research ·Pengfei Wu, (unknown), Qun Chen, (unknown), Jiang Liu, (unknown), Caijun Zha, (unknown), Bosen You, Wenfu Zhang, Lulu Li, Xiangqi Meng, Jinquan Cai, Xuedong Li	35
11	Improving rare disease classification using imperfect knowledge graph 2019 ·BMC Medical Informatics and Decision Making ·Xuedong Li, Yue Wang, (unknown), (unknown), Dezhong Peng, Qiaozhu Mei	23
12	Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma 2019 ·Journal of Translational Medicine ·(unknown), Lihong Li, Wenfu Zhang, Wan‐Hui Wang, (unknown), Bosen You, Xuedong Li	18
13	Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection 2019 ·Journal of Cancer ·Yong Zhang, (unknown), Hua Yang, Liu‐Xiao Yang, Zheng Wang, Xuedong Li, Dan Yin, Ying‐Hong Shi, Ya Cao, Zhi Dai, Jian Zhou, Qing Chen	35
14	Environmental Regulation, Technological Innovation and Sustainable Growth 2018 ·Hongqiao Zhang, Xuedong Li, (unknown)	1
15	Spatial and Temporal Changes in Vegetation Phenology at Middle and High Latitudes of the Northern Hemisphere over the Past Three Decades 2015 ·Remote Sensing ·Jianjun Zhao, Hongyan Zhang, Zhengxiang Zhang, Xiaoyi Guo, Xuedong Li, Chun Chen	106
16	Smad4 suppresses the progression of renal cell carcinoma via the activation of forkhead box protein H1 2014 ·Molecular Medicine Reports ·(unknown), Yangyang Xu, Xuedong Li, Zhaoyan Chen	7
17	Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology 2013 ·International Journal of Pharmaceutics ·Wenji Zhang, Xuedong Li, Tiantian Ye, Fen Chen, (unknown), Jun Kong, Xinggang Yang, Weisan Pan, Sanming Li	76
18	Use of Nonsteroidal Anti-Inflammatory Drugs and Bladder Cancer Risk: A Meta-Analysis of Epidemiologic Studies 2013 ·PLoS ONE ·(unknown), (unknown), Xuedong Li	17
19	Reconstruction of total degloving injuries of the foot in children 2012 ·The Journal of Trauma: Injury, Infection, and Critical Care ·Dongxin Liu, Xuedong Li, Hu Wang, Kaifeng Qiu, Shi‐xin Du	10
20	Effects of glutamine added to enteral nutrition on Peyer's patch apoptosis in severely burned mice 2009 ·Burns ·Jun Fan, (unknown), Guang‐hua Guo, Yong Xie, Xuedong Li, (unknown), (unknown), Wei Feng, Liang Ma	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact